Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple betadine wash before C-Section may slash infection risk

NCT ID NCT07715409

Disease control Sponsor: Mohamed Mousa Mohamed Mousa Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This trial tests whether cleaning the vagina with a betadine solution for 30 seconds just before a cesarean section can lower the chance of wound infections, fever, and uterine infection after surgery. About 600 women having either planned or emergency C-sections will take part. The study compares those who receive the betadine wash plus standard antibiotics to those who receive antibiotics alone.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
povidone-iodine 5% solution applied vaginally before cesarean section
What this could lead to
If effective, this simple, low-cost step could become standard practice to reduce infections after C-sections, benefiting millions of women worldwide.
What could go wrong
This is a single-center trial, and results may not apply to all hospitals or populations. The benefit may be small or absent in women already receiving antibiotics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 600 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2027

An estimate. Start dates often move.

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: \- Women undergoing elective or emergency cesarean section. Received prophylactic antibiotics before surgery Exclusion Criteria: * Active infection No prophylactic antibiotics Chorioamnionitis Placenta previa with antepartum hemorrhage

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cesarean section are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometritis Surgical Wound Infection

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cesarean section Endometritis Surgical site infection

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Al-Azhar University Hospital, Damietta

    Damietta, Damietta Governorate, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.